Showing 901-910 of 1329 results for "".
- Vascular Clinichttps://practicalneurology.com/columns/practice-management/vascular-clinic/31087/Establishing a successful hospital-based stroke program critically depends on unwavering support from hospital administration, a key requirement for Joint Commission on Accreditation of Healthcare Organizations (JCAHO) primary stroke center certification. In his December 2007 article for Practical N
- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31185/Navigating Compensation Challenges in Neurology PracticeRecent analyses reveal a concerning trend for physicians across all medical specialties, including neurology: compensation growth is lagging behind productivity increases and inflation. According to the Medical Group Management Association’s (M
- Income Survey: Surviving the Storm, Steering to Safetyhttps://practicalneurology.com/columns/practice-management/income-survey-surviving-the-storm-steering-to-safety/31315/Income Trends and Challenges in Neurology PracticesA May 2006 issue of *Practical Neurology* presents findings from the fifth annual income survey, highlighting evolving financial dynamics within neurology practices. Over the past decade, neurologists have grappled with declining third-party reimbur
Real-World Experience Using Biomarker Testing for the Evaluation of Acute Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/real-world-experience-using-biomarker-testing-for-the-evaluation-of-acute-traumatic-brain-injury-1/32192/Integrating blood biomarker testing for traumatic brain injury into practice can help address some limitations with existing evaluative methods, leading to more timely and cost-effective diagnosis and improved health-related quality of life for affected individuals.Neuromuscular Notes: New and Emerging Therapies in ALS
https://practicalneurology.com/diseases-diagnoses/neuromuscular/neuromuscular-notes-new-and-emerging-therapies-in-als/32007/New therapies—including antisense oligonucleotides, mesenchymal stem cells, and kinase inhibitors—are in development to target specific pathogenic mechanisms identified in ALS.Real-World Experience Using Biomarker Testing for the Evaluation of Acute Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/imaging-testing/real-world-experience-using-biomarker-testing-for-the-evaluation-of-acute-traumatic-brain-injury/32184/Integrating blood biomarker testing for traumatic brain injury into practice can help address some limitations with existing evaluative methods, leading to more timely and cost-effective diagnosis and improved health-related quality of life for affected individuals.Dystrophinopathies and the Limb-Girdle Muscular Dystrophies
https://practicalneurology.com/diseases-diagnoses/neuromuscular/dystrophinopathies-and-the-limb-girdle-muscular-dystrophies/32028/Disease management for dystrophinopathies and limb-girdle muscular dystrophies has evolved from palliation to genetic therapeutics, paving the way toward a cure.An Update on the Management of Chronic Migraine
https://practicalneurology.com/diseases-diagnoses/headache-pain/an-update-on-the-management-of-chronic-migraine/30697/In 1672, Thomas Willis provided the first description of chronic migraine (CM) when he reported the case of the philosopher, Anne, Viscountess Conway, who was also treated by William Harvey and Robert Boyle without success.1-4 Has our treatment of chronic migraine since improved?The Cognitive and Behavioral Consequences of Hearing Loss, Part 1
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-cognitive-and-behavioral-consequences-of-hearing-loss-part-1/30320/Evidence suggests a causal link between hearing decline and cognitive impairment.The Clinical Features of Migraine With and Without Aura
https://practicalneurology.com/diseases-diagnoses/headache-pain/the-clinical-features-of-migraine-with-and-without-aura/30665/Updates on the clinical features of migraine, especially migraine with aura.